A new study confirms KM118, a proposed biosimilar to pertuzumab, shows pharmacokinetic similarity and safety, paving the way for affordable HER2-positive breast cancer treatments.
Omni NDE cobots, X-ray end effectors and Voxray’s reconstruction approach enables 5-micron inspection of aerospace parts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results